Cancer Family
Skin Neoplasm
CI-CAN-00000051Explore in graph →
Non-malignant347 active trials14 approved drugs74 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000051Explore in graph →
Clinical trials
1,424 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01155609 | L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer | completed | N/A | 10 | University of WashingtonOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT00348985 | PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00068783 | S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00084630 | Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00004241 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00023959 | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00025415 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00492895 | Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients | completed | Phase 4 | 25 | University of ZurichOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT00089271 | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT01464957 | Skin Cancer Prevention in a Pediatric Population | completed | Phase 2 | 867 | University of Colorado, DenverOTHER | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00003970 | Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00077155 | Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00098891 | MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005080 | 506U78 in Treating Patients With Lymphoma | completed | Phase 2 | 74 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00068497 | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer | completed | N/A | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00509288 | Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes | completed | Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Dec 28, 2012 | clinicaltrials |
| NCT00412997 | LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma | completed | Phase 1 | 14 | NovartisINDUSTRY | 1 | Nov 27, 2012 | clinicaltrials |
| NCT00168064 | Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides | completed | Phase 2 | 260 | Yaupon TherapeuticsINDUSTRY | 1 | Oct 31, 2012 | clinicaltrials |
| NCT00849914 | Expression Levels of microRNA Processing Enzymes Dicer and Drosha in Epithelial Skin Cancer | completed | — | 28 | Ruhr University of BochumOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01345760 | Expression Levels of RISC and Microprocessor Complex Components in Epithelial Skin Cancer | completed | — | 44 | Ruhr University of BochumOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01444560 | miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi | completed | — | 21 | Ruhr University of BochumOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01500954 | Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma | completed | — | 7 | Ruhr University of BochumOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00003549 | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | completed | Phase 2 | 80 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00785369 | In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis | completed | N/A | 441 | Lucid, Inc.INDUSTRY | 1 | Oct 3, 2012 | clinicaltrials |
| NCT00824174 | Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer | completed | — | 289 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT00535470 | An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides | completed | Phase 2 | 100 | Yaupon TherapeuticsINDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00836342 | Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer | completed | — | 81 | Massachusetts General HospitalOTHER | 1 | Jul 25, 2012 | clinicaltrials |
| NCT00535769 | Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use | completed | Early Phase 1 | 70 | Massachusetts General HospitalOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT01637194 | Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer | completed | Phase 1 | 12 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00094107 | Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT00346021 | Sun Protection for Florida's Children | completed | N/A | 2,984 | University of South FloridaOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00295958 | LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00129961 | Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients | completed | Phase 4 | 86 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 4 | Apr 11, 2012 | clinicaltrials |
| NCT00243191 | Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans | completed | Phase 2 | 18 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00799461 | Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications | completed | Phase 3 | 1,337 | Fred Hutchinson Cancer Research Center/University of Washington Cancer ConsortiumOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT00578214 | Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery | completed | N/A | 75 | Mayo ClinicOTHER | 1 | Feb 9, 2012 | clinicaltrials |
| NCT00526032 | Melanoma Detection by Oblique-Incidence Optical Spectroscopy | completed | — | 490 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00002882 | Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma | completed | Phase 3 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT00862901 | Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma(CLIPT) | completed | Phase 1 | 48 | Tufts Medical CenterOTHER | 1 | Sep 26, 2011 | clinicaltrials |
| NCT00122473 | Imatinib in Dermatofibrosarcoma Protuberans (DFSP) | completed | Phase 1 / Phase 2 | 30 | Dermatologic Cooperative Oncology GroupOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT00044356 | Phase II Trial of Allovectin-7® for Metastatic Melanoma | completed | Phase 2 | 133 | VicalINDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00615095 | Differential Risks for Melanoma: p16 and DNA Repair | completed | — | 323 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00859768 | The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | completed | N/A | 568 | Netherlands Open UniversityOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT01214564 | Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis | completed | Phase 2 | 24 | PeplinINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00189306 | Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream | completed | Phase 3 | 169 | Graceway Pharmaceuticals, LLCINDUSTRY | 2 | Aug 10, 2010 | clinicaltrials |
| NCT01177371 | High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00765193 | The Impact of Total Body Skin Examination on Skin Cancer Detection(TBSE) | completed | N/A | 14,381 | Medical University of GrazOTHER | 1 | Apr 15, 2010 | clinicaltrials |
Data updated 23 days agoSource updated May 17, 2013source: clinicaltrials